| Ytd | 33.33% | |
| 1y | -13.33% |
| Open | 2.06 | Prev Close | 2.12 | Low | 2.02 | High | 2.12 | Mkt Cap | 55.30M |
| Vol | 432.97K | Avg Vol | 788.57K | EPS | -0.96 | P/E | -2.17 | Forward P/E | -2.23 |
| Beta | 1.85 | Short Ratio | 18.08 | Inst. Own | 24.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.63 | 200-d Avg | 1.55 | 1yr Est | 19.83 |
INmune Bio Inc. (INMB) Q2 2026 Earnings Call Transcript
INmune Bio NASDAQ: INMB outlined plans to file for conditional approval of its Ebstrocel cell therap
BOCA RATON, Fla. , July 31, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"),
Management to host conference call and webcast at 4:30 pm ET on that day BOCA RATON, Fla, July 31, 2
Global Experts in MSC Clinical Translation to Advise Ebstrocel™ Regulatory and Clinical Development
Commercial-Ready Manufacturing Now Supports Planned Phase 3 Confirmation Trial, and US, EU and UK Re
Commercial-Ready Manufacturing Now Supports Planned Phase 3 Confirmation Trial, and US, EU and UK Re
The Department of Defense–funded study; entitled: "Inhibition of Soluble TNF Mitigates Traumatic
The study points to soluble TNF as a key biological link between head injury and Alzheimer's disease
Advanced MRI analyses showed early treatment-related changes in white matter myelin integrity and co
Secures Global Framework for Composition-of-Matter and Method-of-Treatment Claims Covering Lead Prog
Approval of pediatric strategy validates clinical data package and accelerates the regulatory path f
MHRA minutes from May 12 pre-MAA Scientific Advice meeting confirm agreement across all questions co
XPro1595 showed a highly significant treatment effect in the full mITT population (p=0. 0028; d=0. 4
Boca Raton, FL, May 15, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a clinical-stage bi
BOCA RATON, FL, May 14, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a late-stage biotec
Alliance launches with 26 founding companies to develop a national strategy for U.S. biotechnology l
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quart
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss a
Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for i
Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report
During Tuesday's session, 454 stocks hit new 52-week lows.
On Monday, 671 companies achieved new lows for the year.
During Thursday, 166 stocks hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly ea
During Friday's session, 445 companies made new 52-week lows.
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report qu
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnin
Tuesday's morning session saw 269 companies set new 52-week highs.
Gainers Zomedica Corp. (NYSE: ZOM) shares surged 92.2% to close at $0.93 on Monday after surging
Gainers Universal Security Instruments, Inc. (NYSE: UUU) shares climbed 62.3% to close at $5.00 o
Gainers Universal Security Instruments, Inc. (NYSE: UUU) shares jumped 303.2% to $12.42. DPW Hold
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stoc
Stocks That Hit 52-Week Lows On Monday